A Phase I Study of Single Subcutaneous Dose of SHR-1894 in Healthy Subjects
Clinical trial NCT07414602 · RECRUITING
Trial details
- NCT number
- NCT07414602
- Sponsor
- Suzhou Suncadia Biopharmaceuticals Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-16
- Primary completion
- 2026-10-01
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.